
HHS revives child vaccine safety panel sought by anti-vaccine activists
The resurrection of the panel appears to be the first concrete step to achieve HHS Secretary Robert F. Kennedy Jr.'s longtime goal of upending the current childhood immunization schedule, which recommends which shots children receive and when.
The task force will make recommendations focused on developing and refining childhood vaccines that result in 'fewer and less serious adverse reactions,' improving the reporting of adverse reactions and supporting research on vaccine safety, according to HHS. The first report will be sent to Congress within two years.
'By reinstating this Task Force, we are reaffirming our commitment to rigorous science, continuous improvement, and the trust of American families," Jay Bhattacharya, the head of the National Institutes of Health who will lead the task force, said in a statement. 'NIH is proud to lead this effort to advance vaccine safety and support innovation that protects children without compromise."
Congress in 1986 mandated the creation of the task force as part of legislation to address childhood vaccine safety. The Task Force on Safer Childhood Vaccines was disbanded in 1998 and released a report that year recommending an expansion of research on vaccine safety and surveillance of injuries.
Children's Health Defense, an anti-vaccine group founded by Kennedy, funded a lawsuit filed against Kennedy in May, seeking to compel him to reconvene the task force and submit reports to Congress every two years.
Walter Orenstein, a former member of the task force, said reviving the panel isn't necessarily harmful and improvements can still be made to the country's 'really good vaccine safety monitoring system.'
But the revamped task force could be a problem if HHS 'constitutes it with people who are extremely biased, who don't have accepted scientific credentials, who have conflicts of interest,' said Orenstein, who led the U.S. immunization program at the Centers for Disease Control and Prevention from 1988 to 2004.
Senior leaders from federal health agencies, including the NIH, CDC and Food and Drug Administration, will serve on the task force, according to HHS.
Kennedy in June ousted all members of a federal committee of independent vaccine advisers and replaced them with his own appointees, most of whom have criticized coronavirus vaccine policies. Weeks later, that committee announced plans to review the cumulative health effects of the entire childhood vaccination schedule.
The schedule includes more than a dozen routine immunizations, many required by states to attend public school, including measles, mumps and rubella, polio and pertussis.
Studies have found the cumulative effects of the childhood immunization schedule to be safe. Vaccines undergo rigorous safety testing before they are licensed by the FDA and are continuously monitored for safety once they are in use.
While Kennedy said he supports the childhood immunization schedule during his Senate confirmation hearings, he has previously blasted the schedule as 'overburdened' with too many shots and threatening to shorten lives and cause chronic disease.
The May lawsuit aiming to re-establish the task force made similar claims that the schedule included too many vaccines and that the increase in vaccine dosage correlates with the rise of autism. Overwhelming scientific evidence demonstrates no link between immunization and autism.
Sen. Bill Cassidy (R-Louisiana), a physician who chairs the Senate's health committee, publicly grappled with whether to support Kennedy's nomination. He ultimately voted in favor of Kennedy after securing commitments that the then-nominee would protect federal vaccine oversight. That included a pledge that whoever chairs the health committee would get to choose a representative on any board or commission formed to review vaccine safety.
This is a breaking news story and will be updated.
Caitlin Gilbert contributed to this report.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage
Carlsmed Inc. (NASDAQ:CARL), an AI-powered innovator in spine surgery, is poised for significant growth following key advancements and strong analyst projections. The company recently secured additional Medicare reimbursement for its aprevo personalized interbody implants for cervical fusion procedures, effective October 1, enhancing its financial outlook. This favorable reimbursement, granted through the Centers for Medicare & Medicaid Services' (CMS) New Technology Add-On Payment (NTAP) program in the Hospital Inpatient Prospective Payment Systems (IPPS) Final Rule for fiscal year 2026, means cervical fusion procedures using aprevo devices will be eligible for an additional $21,125 beyond standard Medicare Severity-Diagnosis-Related Groups (MS-DRGs) for qualifying inpatient benefit extends to private payors as well, utilizing unique ICD-10-PCS procedure codes. Carlsmed, which priced its initial public offering of 6.7 million shares at $15 per share in July, focuses on AI-enabled personalized spine surgery solutions. Its aprevo cervical system, having received FDA Breakthrough Device designation, is anticipated for a U.S. commercial launch in of America Securities (BofA) has initiated coverage on Carlsmed with a Buy rating and a price forecast of $16, recognizing the company's potential to establish a new standard of care in spine fusion. BofA analyst Travis Steed highlighted Carlsmed's differentiated technology and robust outlook, assigning a premium valuation of 5x 2026 estimated revenue. This premium, higher than recent medtech IPOs and other spine companies, is justified by Carlsmed's projected high revenue growth and strong gross margin profile. BofA conservatively forecasts Carlsmed will add around 20-25 new surgeons each quarter through 2027, indicating a steady increase in adoption. Carlsmed forecasts impressive top-line growth: 66% in 2025 and an annual 40-45% through 2028. Its asset-light business model is expected to support profitability, with gross margins in the mid-70s and capital expenditures at just 1% of sales, significantly lower than the approximately 10% for traditional spine peers. BofA estimates the total spine market at roughly $1.4 billion, with a compound annual growth rate (CAGR) of approximately 1.5%. In the first quarter of 2025, the global spine market (including biologics) saw 2.6% organic growth, driven by a 4.1% increase in the U.S. market. Despite the market being largely commoditized and dominated by major players like Medtronic Plc (NYSE:MDT), Globus Medical Inc (NYSE:GMED), Alphatec Holdings Inc. (NASDAQ:ATEC), Johnson and Johnson (NYSE:JNJ), and Orthofix Medical Inc. (NYSE:OFIX) (who collectively hold about 70% of the market), spine surgeons notably favor new technology. The remaining 30% of the market is split among many smaller companies, creating an opportunity for new market entrants with disruptive technology like Carlsmed's to gain traction. BofA sees significant market share capture potential for Carlsmed, with analyst Steed estimating total revenue of $133 million in 2028, representing only about 1% of the total U.S. spine market. Price Action: CARL stock is trading higher by 0.88% to $13.70 at last check Monday. Read Next:Photo via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantage originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
11 minutes ago
- Yahoo
Trump vows to end mail-in ballots with executive order
Former President Donald Trump said Monday that he plans to sign an executive order aimed at ending mail-in voting and eliminating voting machines, a proposal that election experts note he cannot carry out on his own. Trump has long criticized mail-in ballots, calling them fraudulent. On his Truth Social account, Trump wrote: 'THE MAIL-IN BALLOT HOAX, USING VOTING MACHINES THAT ARE A COMPLETE AND TOTAL DISASTER, MUST END, NOW!!!' He also said his order would 'help bring HONESTY to the 2026 Midterm Elections.' According to the New York Times, the Constitution gives states the authority to set the 'times, places and manner' of elections, with Congress able to override state rules. That means Trump could not unilaterally end mail-in voting or require states to stop using voting machines, even if he returns to office. KIRO 7 News has reached out to the office of Gov. Ferguson for comment. California Governor Gavin Newsom responded to Trump, saying on X, 'His plan to rig new Congressional seats is going to backfire — thanks to he's clamoring for other ways to cook the results." Trump claimed in his post that states serve as 'merely an agent' for the federal government in counting ballots and that they must follow the president's instructions. Legal scholars say this interpretation is at odds with constitutional law and decades of precedent. He also repeated an inaccurate assertion that the United States is the 'only Country in the World that uses Mail-In Voting.' In reality, many democracies, including Canada, Germany, and the United Kingdom, allow citizens to vote by mail under certain conditions. Trump's position comes despite evidence that Republicans made gains in mail-in voting during the 2024 elections after the party encouraged supporters to use it. In past elections, skepticism toward the practice had sometimes disadvantaged GOP candidates, as Democrats more often embraced early and absentee ballots. In his Truth Social post, Trump argued that Democrats are 'virtually Unelectable' without mail-in voting. He also said that electronic voting machines are inaccurate and expensive. His remarks followed a recent summit with Russian President Vladimir V. Putin in Alaska. Trump told Fox News that Putin agreed with him that the 2020 election was 'rigged' because of mail-in ballots, quoting Putin as saying, 'Your election was rigged because you have mail-in voting.' It remains unclear what language Trump's proposed executive order would contain or how he would attempt to enforce it, given that election administration is largely managed at the state level.
Yahoo
11 minutes ago
- Yahoo
Measles outbreak ends in West Texas, health officials say
(Reuters) -The measles outbreak in West Texas has ended, state health officials said on Monday, after meeting the criteria of six weeks since the last reported case. Texas is now shifting focus to vaccination campaigns to strengthen immunity and prevent future outbreaks, the Department of State Health Services (DSHS) said. The outbreak, which began in late January, led to 762 confirmed cases as of August 18, with 99 hospitalizations and two fatalities in school-aged children, according to the state's health department. Texas led a surge in cases nationally, with the United States recording its largest outbreak since the disease was declared eliminated in the United States in 2000. While the Texas DSHS will continue to monitor the cases, it has decided to discontinue its interactive outbreak dashboard. "The end of this outbreak does not mean the threat of measles is over. Since there are ongoing outbreaks of measles in North America and around the world, it is likely that there will be additional cases of measles this year in Texas," the DSHS said. Measles is a highly contagious viral infection that causes symptoms such as fever, cough and a characteristic rash. It can also lead to severe complications like pneumonia and encephalitis. The Centers for Disease Control and Prevention has reported 1,356 confirmed measles cases nationally as of August 5, but the updates have been delayed following the August 8 shooting on its Atlanta headquarters, the CDC said. "We remain in close communication with public health partners and jurisdictions reporting measles and will resume regular data updates as soon as possible," a CDC spokesperson said. Solve the daily Crossword